Lastly, the expression and activation of Notch receptors (Notch1, Notch2, Notch3, and Notch4) are closely associated with aggressive clinical and biological features of BC, including invasiveness and chemoresistance [176,177]. This evidence concerns the gene NOTCH1 and breast cancer.